# The Clinical and Economic Impact of Pharmacogenomic Testing of Warfarin Therapy in Typical Community Practice Settings

> **NCT00830570** · — · COMPLETED · sponsor: **Medco Health Solutions, Inc.** · enrollment: 1635 (actual)

## Conditions studied

- Embolism and Thrombosis
- Embolism
- Vascular Diseases
- Warfarin
- Venous Thromboembolism
- Thrombosis
- Thromboembolism

## Interventions

- **OTHER:** CYP 2C9 and VKORC1 Testing for Warfarin

## Key facts

- **NCT ID:** NCT00830570
- **Lead sponsor:** Medco Health Solutions, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2007-07
- **Primary completion:** 2010-01
- **Final completion:** 2010-01
- **Target enrollment:** 1635 (ACTUAL)
- **Last updated:** 2010-11-16

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00830570

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00830570, "The Clinical and Economic Impact of Pharmacogenomic Testing of Warfarin Therapy in Typical Community Practice Settings". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00830570. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*